Reshma Kewalramani
CIK 1735944 · CEO & President · last filed 2026-03-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$69.83M
Companies
2
Total Filings
76
Lifetime Open-Market Net
-$74.81M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRTX | CEO & President | 127,596 | $547.29 | $69.83M | -$74.81M | 59 | 2026-03-03 |
| Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Director | 186,002 | $0.01 | $1.2K | $0 | 6 | 2024-06-14 |
Recent Filings · Page 3 of 8
76 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-14 | Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | Exer (M) | +105,263 | $0 | EDGAR |
| 2024-05-29 | VRTX | Mixed | — | -$421.7K | EDGAR |
| 2024-05-24 | VRTX | Notice (144) | −1,565 | -$715.2K | EDGAR |
| 2024-05-22 | VRTX | Sell (S) | −15,202 | -$6.80M | EDGAR |
| 2024-05-20 | VRTX | Notice (144) | −15,202 | -$6.80M | EDGAR |
| 2024-02-27 | VRTX | Tax (F) | −9,386 | -$4.05M | EDGAR |
| 2024-02-21 | VRTX | Tax (F) | −16,378 | -$6.92M | EDGAR |
| 2024-02-13 | VRTX | Tax (F) | −8,255 | -$3.49M | EDGAR |
| 2024-02-08 | VRTX | Grant (A) | +61,815 | $0 | EDGAR |
| 2023-12-19 | VRTX | Mixed | — | -$3.86M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.